Sabra Healthcare REIT, Inc. (SBRA) To Go Ex-Dividend on August 14th

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend on Monday, August 3rd. Investors of record on Friday, August 14th will be paid a dividend of 0.30 per share by the real estate investment trust on Monday, August 31st. This represents a c) dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend is Friday, August 14th.

Sabra Healthcare REIT has decreased its dividend payment by an average of 0.0%per year over the last three years. Sabra Healthcare REIT has a dividend payout ratio of 153.8% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect Sabra Healthcare REIT to earn $1.59 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 75.5%.

Sabra Healthcare REIT Stock Down 4.0%

SBRA stock opened at $19.85 on Wednesday. Sabra Healthcare REIT has a one year low of $17.17 and a one year high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The firm’s fifty day moving average is $19.87 and its 200 day moving average is $20.00. The firm has a market cap of $5.07 billion, a PE ratio of 76.35, a P/E/G ratio of 1.60 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). The firm had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The company’s revenue was up 24.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.38 earnings per share. On average, research analysts forecast that Sabra Healthcare REIT will post 1.51 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on SBRA. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. UBS Group set a $25.00 price objective on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Scotiabank decreased their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Robert W. Baird lifted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.